schliessen

Filtern

 

Bibliotheken

1.

A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer.
by Reckamp, Karen L

Clinical cancer research : an official journal of the American Association for Cancer Research, June 1, 2006, Vol.12(11 Pt 1), pp.3381-3388

1

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 1 Hits

Remove Filters